ULURU

Biopharma, Biotechnology, Pharmaceutical
Founded in 1987-01-01
Addison, Texas, United States
http://www.uluruinc.com
For Profit

About ULURU

ULURU is a specialty pharmaceutical company, engages in the research, development, and commercialization of wound care and mucoadhesive film products in the United States and internationally. The company’s products are based on patented Nanoflex and OraDisc drug delivery technologies. Its products include Altrazeal, a transforming powder dressing for the treatment of various wounds, such as partial-thickness burns, donor sites, and abrasions, as well as surgical, acute, and chronic wounds; Aphthasol and Aptheal for the treatment of canker sores; OraDisc A for the treatment of oral conditions, which rely upon the use of medications formulated as gels and pastes that are applied to lesions in the mouth; and OraDisc B, a mucoadhesive disc product for the treatment and management of oral pain. The company was founded in 1987 and is based in Addison, Texas.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: 11 active products

Financial Information

  • Estimated Revenue: Less than $1M
  • Total Funding: 4866600 USD
  • Last Funding: 1714000 USD (Post-IPO Equity)
  • Funding Status: IPO

Technology Stack

ULURU actively uses 11 products in their tech stack.

Market Presence

Industries: Biopharma, Biotechnology, Pharmaceutical

Headquarters: Addison, Texas, United States